BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/26/2018 9:00:43 AM | Browse: 1392 | Download: 2917
 |
Received |
|
2018-06-08 01:27 |
 |
Peer-Review Started |
|
2018-06-08 12:00 |
 |
First Decision by Editorial Office Director |
|
2018-07-03 16:00 |
 |
Return for Revision |
|
2018-07-13 01:11 |
 |
Revised |
|
2018-08-22 07:51 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2018-08-27 09:23 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2018-08-28 02:53 |
 |
Articles in Press |
|
2018-08-28 02:53 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2018-09-24 03:55 |
 |
Publish the Manuscript Online |
|
2018-09-26 09:00 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Retrospective Study |
| Article Title |
Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Deng-Feng Ren, Fang-Chao Zheng, Jun-Hui Zhao, Guo-Shuang Shen, Raees Ahmad, Shui-Sheng Zhang, Yu Zhang, Jie Kan, Li Dong, Zi-Yi Wang, Fu-Xing Zhao and Jiu-Da Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Thousand Talents of Program of High-end Innovation of Qinghai Province in China |
|
| the Clinical Oncology Medical Center of Qinghai Province in China |
2018-SF-113 |
|
| Corresponding Author |
Jiu-Da Zhao, MD, Professor, Department of Medical Oncology, Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, No. 29, Tongren Road, Xining 810000, Qinghai Province, China. jiudazhao@126.com |
| Key Words |
Gastric cancer; D2 gastrectomy; Adjuvant chemotherapy; S-1; Oxaliplatin; Capecitabine |
| Core Tip |
Based on the therapeutic efficacy of both S-1 mono-therapy and oxaliplatin plus capecitabine regimen in ACTS-gastric cancer (GC) and CLASSIC study, we conducted the multi-institutional research using propensity score-matched analysis to evaluate whether patients after D2 resection benefit from adjuvant chemotherapy with S-1 plus oxaliplatin (SOX). Here, we firstly report that SOX adjuvant chemotherapy, compared with surgery alone, significantly improves disease-free survival and overall survival in stage ⅠB-ⅢC GC patients undergoing D2 resection with accepted side effects. |
| Publish Date |
2018-09-26 09:00 |
| Citation |
Ren DF, Zheng FC, Zhao JH, Shen GS, Ahmad R, Zhang SS, Zhang Y, Kan J, Dong L, Wang ZY, Zhao FX, Zhao JD. Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study. World J Clin Cases 2018; 6(10): 373-383
|
| URL |
http://www.wjgnet.com/2307-8960/full/v6/i10/373.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v6.i10.373 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.